EP Patent

EP0978275A1 — Solid pharmaceutical dosage form with controlled drug release

Assigned to Pharma Pass SA · Expires 2000-02-09 · 26y expired

What this patent protects

The invention relates to a pharmaceutical dosage form comprising a core containing at least part of an active ingredient, and a functional film coating ensuring controlled onset of the release of the active ingredient contained in the core. The film coating comprises at least one…

USPTO Abstract

The invention relates to a pharmaceutical dosage form comprising a core containing at least part of an active ingredient, and a functional film coating ensuring controlled onset of the release of the active ingredient contained in the core. The film coating comprises at least one excipient ensuring gastro-resistance and one substance creating an acidic pH in the functional film coating. The invention allows a lag time between the administration of the pharmaceutical dosage form and the beginning of the release of the drug, said lag time being adjustable to a predefined duration by appropriate formulation. As an example of therapeutic application, the invention provides a dosage form that may release its active ingredient a few hours after administration and is of great interest for reducing some nocturnal occurring diseases, such as ischemic heart attack, asthma or arthritis.

Drugs covered by this patent

Patent Metadata

Patent number
EP0978275A1
Jurisdiction
EP
Classification
Expires
2000-02-09
Drug substance claim
No
Drug product claim
No
Assignee
Pharma Pass SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.